Brief: Processa Pharmaceuticals, Inc. Announces Closing Of $6.25 Million Registered Direct Offering, Which Included Retail Investors And Insiders, Priced At The Market Under Nasdaq Rules
15/02/2023 14:16
Feb 15 (Reuters) - Processa Pharmaceuticals Inc
PCSA.O :
* PROCESSA PHARMACEUTICALS, INC. ANNOUNCES CLOSING OF $6.25
MILLION REGISTERED DIRECT OFFERING, WHICH INCLUDED RETAIL
INVESTORS AND INSIDERS, PRICED AT THE MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nGNX3XKdW1
Further company coverage: PCSA.O
((Reuters.Briefs@thomsonreuters.com;))